Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Looking for under-the-radar adventures? Try Norway's Vesterålen - 2NATO needs Ukraine's 'adaptation DNA' and an 'HOV lane' for new war tech, top commander says
- 3Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
- 4AfD faction in western Germany ousts councilman for firebrand speech
- 5Figure out How to Use the Experience of a Fender bender Legal counselor for Your Potential benefit
- Shadow Cats: The Elusive Leopards Surviving Against Impossible Odds
- Nations for Rock Climbing
- Stunning new James Webb Space Telescope images reveal 'hidden' stars being born
- The most effective method to Pick a Campervan That Offers Something else for Less
- ‘Extraordinary’ Iron Age war trumpet uncovered in England
- 2 new malaria treatments announced as drug resistance grows
- Longtime United Launch Alliance CEO Tory Bruno resigns from space company. 'Finished the mission I came to do.'
- Tragedy in Minnesota, vaccine news, Snoop's game call: Week in review
- The Best 15 Applications for Efficiency and Association
